Publication

History and Evolution of Innovations in Clinical Pharmacology

This paper reviews how decades of scientific and technological advances have transformed clinical pharmacology and…

Danielle Pillsbury2025 年 11 月 26 日

Publication

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…

Certara2025 年 11 月 26 日

Blog

The stepwise PIP is here to stay: From pilot flexibility to permanent EU regulation

The stepwise Paediatric Investigation Plan (PIP) is a strategic, flexible route for drug developers navigating…

Certara2025 年 11 月 26 日

Blog

Using M&S to evaluate oncology drug dosing

Learn how modeling & simulation improves oncology drug dosing, optimizing safety, efficacy, and personalized treatment…

Certara2025 年 11 月 14 日

Blog

ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

Certara2025 年 11 月 13 日

On-Demand Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…

Certara2025 年 11 月 13 日

Announcement

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Certara’s new survey findings show that 50% of Americans are unaware of FDA and NIH…

Certara2025 年 11 月 12 日

On-Demand Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

In today’s market where long development timelines and investor caution can slow progress, MIDD offers…

Certara2025 年 11 月 10 日

Guide

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Learn how Early Feasibility Assessment and QSP modeling improve drug design, de-risk feasibility studies, &…

Certara2025 年 11 月 7 日

On-Demand Webinar

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

Watch the on-demand webinar on avoiding drug launch failure. Learn how smarter development, evidence, and…

Certara2025 年 11 月 6 日

建模与模拟

History and Evolution of Innovations in Clinical Pharmacology

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

The stepwise PIP is here to stay: From pilot flexibility to permanent EU regulation

Using M&S to evaluate oncology drug dosing

ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Certara 一项研究显示，半数美国人不知道 FDA 和 NIH 正计划逐步淘汰新药的动物实验

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

降低药物设计风险：早期可行性评估如何改变生物治疗药物的研发

Failure to Launch: Building Smarter Strategies to Get the Right Drug to the Right Patient

订阅时事通讯

快捷链接

解决方案

联系我们